ArticleMagma (New York, N.Y.)2026
Deep learning synthesis of Restriction Spectrum Imaging cellularity maps from conventional MRI in post-treatment glioblastoma.
Article in Magma (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe feasibility of synthesizing Restriction Spectrum Imaging (RSI) cellularity maps from routinely acquired post-treatment MRI in glioblastoma was evaluated using a deep learning framework. MATERIALS AND
methodsA SwinUNETR model was trained on post-contrast T1-weighted, FLAIR, and ADC images from 184 imaging timepoints of 136 patients in the publicly available UCSD-PTGBM dataset, using five-fold patient-level cross-validation. Synthesis performance was assessed using tumor-ROI Pearson correlation as the primary endpoint, alongside secondary clinical agreement, hotspot localization, and scanner-stratified analyses.
resultsMean per-visit tumor-ROI Pearson correlation was 0.635 ± 0.164 (95% CI 0.608-0.662) and voxel-level intratumoral rank-agreement AUC for high-cellularity voxels was 0.800 (95% CI 0.785-0.814). SwinUNETR outperformed a 3D U-Net baseline across prespecified agreement and error metrics (all p < 0.001). A systematic negative bias of - 0.058 (95% limits-of-agreement width: 0.428) was observed within the tumor ROI, and hotspot Dice was 0.155 (95% CI 0.144-0.166), indicating limited focal localization. No significant difference was observed between scanner models for primary agreement metrics. DISCUSSION: Conventional post-treatment MRI approximates average RSI-derived cellularity but not the high-cellularity subregions with spatial precision. The approach may support screening where dedicated RSI is unavailable but cannot substitute for acquired RSI in quantitative or treatment-guiding applications.
Indexed as
Identifiers
42709316What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.